‘Young blood’ latest age-fighting fad

Jesse Karmazin, a 32-year-old Princeton graduate and competitive rower who has an MD but no licence to practise medicine, claims he can reverse ageing with transfusions of a young person’s plasma. He is now launching a clinical trial on the potential of “young blood” through his startup Ambrosia. Karmazin claims most participants see improvements within a month of getting the $8,000 one-time infusion of a two litre bagful of plasma, which is blood with the blood cells removed. But many scientists and clinicians say Karmazin’s trial is so poorly designed…

Read More